Proteomic Data from Immunovia’s Immray Platform Helps Diagnose Autoimmune Diseases
These are the first proteomic data allowing a differential analysis of four different inflammatory rheumatic diseases.
Category: Allergy & Autoimmune
Allergy & Autoimmune
Latest
Allergy & Autoimmune
Latest
Study Demonstrates Clinical Utility and Accuracy of Panel Test for Patients with Symptoms of Autoimmune Encephalopathy
A study found positive correlations between Cunningham panel assay results and patients’ neuropsychiatric symptoms.
Allergy & Autoimmune
Popular
Allergy Testing Instrument Gets CE Mark
Hycor Biomedical has applied the CE mark to its Noveos allergy testing system, along with an initial menu of more than 100 specific immunoglobulin E allergen reagents.
Camel Immunization Could Provide New Hope for Allergy Sufferers
New research could lead to the availability of nasal sprays or eye drops to treat seasonal pollen allergies in as little as 8 to 10 years.
Read More
Assay Supports Drug Development for Autoimmune Disease
The disease stratification assay is designed to support pharmaceutical and biotechnology companies with their drug development efforts for systemic sclerosis.
Read More
United Rheumatology Adds Multibiomarker Blood Test to Clinical Guidelines
The guidelines are designed to assist healthcare professionals in the diagnosis, treatment, and monitoring of patients with rheumatoid arthritis.
Read More
Environmental Trigger Test Evaluates Latent Pathogens
The test assesses the immune load from 29 bacterial, fungal, parasitic, stealth, and viral organism antigens that may be latent in the body.
Read More
Tests Facilitate Autoimmune Thyroid Disease Management
The tests quantitatively measure a patient’s autoantibodies to thyroglobulin or thyroid peroxidase, providing information that can help clinicians in the diagnosis of autoimmune thyroid disease.
Read More
Protagen Joins Global Consortium Examining Rheumatoid Arthritis
The RA-MAP consortium aims to identify clinical, molecular and cellular biomarkers of prognosis and therapeutic response in patients with early RA.
Read More
FDA Clears Nut Allergen Component Tests
The allergen component tests by Thermo Fisher Scientific detect immunoglobulin E sensitization to hazelnut, walnut, and cashew nut proteins.
Read More
Allergies and Autoimmune Diseases
The incidence of allergies and autoimmune diseases has been increasing over the past several decades, with both diseases rising to become a major women’s issue.
Read More
Rheumatoid Arthritis Blood Test Gains Expanded Use Indications
In addition to assisting with early diagnosis, the test’s expanded indications support treat-to-target objectives by allowing close monitoring of 14-3-3η levels along the clinical management path to detect how active the joint damage processes are.
Read More
Autoimmune Platform Holds 800 Tubes
Thermo Fisher Scientific’s Phadia 2500EE, a dedicated autoimmune platform that streamlines operational efficiency, will be featured at AACC booth 3564.
Read More
Immunovent’s Test Aims to Uncover Allergies That Current Allergy Tests Cannot
For Immunovent’s innovative approach to allergy diagnosis, MABA names the company the “best of the best” in its year-end first pitch life science competition.
Read MoreEuropean Deals Widen Availability of Blood Thinner Allergy Assay
Akers Biosciences has entered into multiyear distribution agreements with Cryopep SARL and DiaLine AG for its PIFA Heparin and PF4 rapid assay products, which determine whether a patient being treated with the blood thinner heparin may be developing a drug allergy.
Read More
FDA Authorizes First Commercially Available Screening Test for Severe Combined Immunodeficiency
The Victor EnLite and EnLite Neonatal TREC kit from PerkinElmer is the first commercially available screening test in the United States and Canada for severe combined immunodeficiency, known as “Bubble Boy” disease. Affecting an estimated 1 in 58,000 newborns each year, SCID is an inherited genetic condition that makes it extremely difficult to fight off infections.
Read More
The Food-Sensitization Dilemma
Clinicians and their patients face a dilemma: Patient histories are often unclear, and sensitization alone does not necessarily predict risk for severe systemic reactions.
Read More
Expanded Access to Thermo’s Peanut Allergy Tests through Collaboration with Quest Diagnostics
Quest is the first national company to broadly offer the first and only FDA-cleared component tests able to detect IgE sensitization to five peanut proteins, some of which can cause severe patient reactions.
Read More